Nuveen’s Chembio diagnostics, Inc. CEMI Stock Holding History

Nuveen’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-58,308	Closed	-$204K	–	3665
2021 Q1	$204K	Sell	58,308 -4,964	-8%	-$27.6K	﹤0.01%	3230
2020 Q4	$300K	Sell	63,272 -109,275	-63%	-$564K	﹤0.01%	3138
2020 Q3	$839K	Buy	172,547 +62,335	+57%	+$295K	﹤0.01%	2759
2020 Q2	$358K	Buy	+110,212	New	+$1.05M	﹤0.01%	3007

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Nuveen's CEMI Position: Q2 2021 in Review

Nuveen sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 58,308 shares — an estimated $204K sold.

Nuveen first reported a position in CEMI in Q2 2020 and held it in 4 quarters. The position peaked at $839K in Q3 2020. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

Nuveen reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
Nuveen sold 58,308 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $204K.
Nuveen first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 4 quarters.
Nuveen's Chembio diagnostics, Inc. position peaked at $839K in Q3 2020.
60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.